HEALTH● LOW1h ago · Sep 8, 2026, 11:20 AM
Bristol Myers succeeds in mid-stage trial for CAR-T cell therapy in multiple myeloma
Seeking Alpha Tech · global
Bristol Myers has achieved success in a mid-stage trial for its CAR-T cell therapy, which targets multiple myeloma. This marks progress in the development of treatments for the condition.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH30m agoAbbott granted FDA nod for advanced cardiac ablation catheterSeeking Alpha TechHEALTH47m agoSudan’s healthcare system on brink of collapse, MSF warnsAl Jazeera [en]HEALTH56m agoAstraZeneca's COPD drug scores two late-stage trial wins as full data boosts blockbuster hopesCNBCHEALTH1h agoTobacco use can undermine fertility, UN health agency warnsUN News